"Fibrinolytics" Pronounce,Meaning And Examples
"Fibrinolytics" Natural Recordings by Native Speakers
"Fibrinolytics" Meaning
Fibrinolytics are a type of medication used to break down blood clots and promote blood flow. They work by converting plasminogen, a protein in the blood, into plasmin, an enzyme that dissolves blood clots. Fibrinolytics are often used to treat conditions such as deep vein thrombosis, pulmonary embolism, and myocardial infarction (heart attack). Examples of fibrinolytics include tissue plasminogen activator (tPA) and streptokinase.
"Fibrinolytics" Examples
Fibrinolytics Examples:
Use case 1: Medical treatment
Fibrinolytics are a class of medications used to break down blood clots, which can help treat conditions such as pulmonary embolism or deep vein thrombosis.
Example sentence: The doctor prescribed a fibrinolytic medication to dissolve the blood clot in the patient's lung.
Use case 2: Medical research
Fibrinolytic enzymes play a crucial role in the body's natural process of clot dissolution, which is essential for preventing excessive clotting and maintaining blood flow.
Example sentence: In the study, researchers investigated the mechanisms by which fibrinolytic enzymes help to regulate clot formation and dissolution.
Use case 3: Clinical practice
Fibrinolytic therapy is often used in combination with other treatments, such as catheter-directed thrombolysis, to treat patients with acute limb ischemia.
Example sentence: The interventional radiologist performed catheter-directed thrombolysis and fibrinolytic therapy to restore blood flow to the patient's affected limb.
Use case 4: Medical terminology
Fibrinolysis is the process by which fibrinolytic enzymes break down blood clots, and fibrinolytic agents are medications that stimulate this process.
Example sentence: The patient was diagnosed with disseminated intravascular coagulation and required fibrinolytic agents to dissolve the blood clots causing the condition.
Use case 5: Pharmaceutical development
Pharmaceutical companies are actively developing new fibrinolytic agents to improve treatment outcomes for patients with venous thromboembolism and pulmonary embolism.
Example sentence: The pharmaceutical company invested heavily in research and development to create a novel fibrinolytic agent with improved efficacy and reduced side effects.
"Fibrinolytics" Similar Words
Fibrination
Fibrination refers to the process by which a liquid protein, such as fibrinogen, is converted into a solid fibrin thread or clot, often as a result of blood clotting.
Fibrine
Fibrin is a type of protein that forms a blood clot by combining with other blood components, helping to stop bleeding.
Fibrinogen
Fibrinogen is a type of protein that plays a crucial role in blood clotting. It is a soluble glycoprotein produced by the liver that circulates in the bloodstream. When a blood vessel is injured, fibrinogen is converted into fibrin, which forms a mesh-like structure that traps red blood cells and platelets, ultimately creating a clot that stops bleeding. Fibrinogen is often referred to as "clotting factor I" and is an essential component of the body's hemostatic response, helping to prevent excessive blood loss following an injury.
Fibrinogenous
Fibrinogenous refers to something that is capable of producing or forming fibrin, a type of protein that plays a crucial role in blood clotting.
Fibrinoid
Fibrinoid refers to a type of amorphous, granular, or proteinaceous substance that forms in tissues and organs, often as a result of inflammation or disease. It is typically composed of a mixture of fibrin, a protein produced by blood platelets, and other substances such as collagen, elastin, and mucopolysaccharides. Fibrinoid material can deposited in the walls of blood vessels, in skin, in connective tissue, and in other parts of the body. It is often seen in conditions such as rheumatic fever, lupus, and vasculitis.
Fibrinolysin
Fibrinolysin is an enzyme that breaks down fibrin, a protein that forms blood clots. It is an important component of the body's natural process of blood clotting resolution, helping to dissolve and remove blood clots after they are no longer needed. Fibrinolysin is often used as a therapeutic agent to treat conditions such as deep vein thrombosis and pulmonary embolism.
Fibrinolysis
Fibrinolysis is the process by which the blood breaks down and dissolves blood clots. It is an important part of the body's natural response to injury or inflammation, as it helps prevent excessive clotting and ensures that blood flow is restored to affected areas. Fibrinolysis is mediated by enzymes such as plasminogen activators, which convert plasminogen to plasmin, a protease that degrades fibrin, the main component of blood clots.
Fibrinolytic
Fibrinolytic refers to a substance or process that breaks down fibrin, a blood protein that forms clots. Fibrinolytic agents are used to dissolve blood clots and restore blood flow in the body. They are often used in medical treatments for conditions such as acute myocardial infarction, deep vein thrombosis, and pulmonary embolism.
Fibrinoplastic
Fibrinoplastic is a term used in medicine, specifically in the field of ophthalmology and plastic surgery. It refers to a type of tissue growth that occurs in response to injury or trauma, characterized by the deposition of fibrin, a protein that helps blood to clot, along with the proliferation of fibroblasts, which are cells that produce collagen.<br><br>In other words, fibrinoplastic growth is a type of scarring or fibrosis that occurs when the body attempts to repair an injury or trauma, resulting in the formation of a fibrous tissue that can be stiff, hard, and non-functioning. This phenomenon is often seen in cases of ocular injuries or surgeries, such as cataract surgery, as well as in burn wounds or other types of trauma.
Fibrinoplastin
Fibrinoplastin is an obsolete term that refers to a protein that was previously believed to play a role in blood clotting. However, it is now known that fibrin is the main protein involved in blood clotting, and fibrinoplastin is no longer considered a valid or useful term in medical or biological contexts.
Fibrinous
Fibrinous refers to something that is relating to or consisting of fine thread-like fibers or filaments, typically in a shapeless or irregular mass. In medical contexts, fibrinous often refers to a type of tissue that forms as a result of inflammation or blood clotting, characterized by the presence of a loose network of fibers or strands.
Fibroadenoma
A fibroadenoma is a type of benign tumor that typically occurs in the breast tissue of females. It is the most common type of breast tumor in young women. Fibroadenomas are non-cancerous and usually do not cause any symptoms, but they can present as a lump or nodule in the breast tissue that is usually palpable (can be felt). In most cases, fibroadenomas are treated with a biopsy, and if diagnosed, they do not require further treatment as they are not cancerous.
Fibroadenomas
Fibroadenomas are benign breast tumors that are typically non-cancerous and do not spread to other parts of the body. They are the most common type of non-cancerous breast tumor, accounting for about 70% of all benign breast tumors. Fibroadenomas are usually small, firm, and mobile, and can appear in both men and women. They are often diagnosed incidentally, during a routine breast exam or mammogram. While they are generally harmless, fibroadenomas can cause some discomfort, and in rare cases, they may need to be removed surgically if they become painful or interfere with breastfeeding.
Fibroadenomata
Fibroadenomata are benign tumors that typically occur in the breast tissue of young women. They are also known as breast hamartomas or fibroadenomas. They are usually round, firm, and mobile, and are often found in the upper outer quadrant of the breast. Fibroadenomata are non-cancerous and do not usually cause any symptoms, but can sometimes cause discomfort or abnormal milk production. They are usually treated with removal, but most do not require treatment if they are small and benign.
Fibroadenomatous
Fibroadenomatous refers to a type of disease or condition characterized by the presence of both fibrous and glandular tissue. In medical contexts, fibroadenomatous lesions or tumors can occur in various parts of the body, such as the breast, uterus, or thyroid gland. The term suggests a mix of fibrous tissue (connective tissue that provides structural support) and glandular tissue (specialized cells that produce secretions or hormones), often indicative of a benign or non-cancerous condition.
Fibroadenosis